The Effect of Digital Education for Osteoporosis Patients on Fracture Risk and Related Health Outcomes.
Launched by SAHLGRENSKA UNIVERSITY HOSPITAL · Sep 16, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating the effects of a digital education program designed for patients with osteoporosis. The goal is to see if this program can help reduce the risk of fractures and improve overall health outcomes for older adults. Specifically, the study will compare the new digital education approach with standard care to see if it leads to fewer fractures, better adherence to osteoporosis medications, improved diets, increased physical activity, and a better quality of life for people aged 65 and older who have been advised to start treatment for osteoporosis.
To participate in the trial, individuals must be at least 65 years old, have been evaluated for osteoporosis at a clinic, and have been recommended medication for treatment. Participants will be randomly assigned to either receive the digital education program or the usual care provided at the clinic. It’s important to note that those who have taken osteoporosis medication in the past year are not eligible for the study. If you or someone you know meets these criteria, this trial offers a chance to potentially benefit from an innovative approach to osteoporosis management.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients visiting an osteoporosis unit, 65 years and older.
- • Ability to understand and follow study instructions.
- • Signed informed consent.
- • Have been recommended pharmacological osteoporosis treatment after a clinical evaluation including a DXA-scan and assessment of fracture risk at an osteoporosis clinic.
- • Have access to www.1177.se.
- Exclusion Criteria:
- • Patients with previous osteoporosis medication the last year.
About Sahlgrenska University Hospital
Sahlgrenska University Hospital, a leading healthcare institution in Sweden, is at the forefront of clinical research and innovation. Affiliated with the University of Gothenburg, the hospital integrates advanced medical care with cutting-edge research, facilitating a collaborative environment for scientific exploration and clinical trials. With a commitment to improving patient outcomes, Sahlgrenska University Hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise to advance healthcare solutions. The institution is dedicated to fostering ethical research practices and ensuring the highest standards of patient safety and care in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mattias Lorentzon, MD, PhD
Principal Investigator
Sahlgrenska University Hospital, Västra Götalandsregionen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported